Kincell Bio, a leading U.S. cell therapy contract development and manufacturing organization (CDMO), today announced a new collaboration with RegCell, a biotechnology company developing first‑in‑class ...

Engineering regulatory T cells (Tregs) has emerged as a powerful strategy to achieve durable, antigen-specific immune tolerance for autoimmune and ...

CELZ-101 (etaroleucel) is designed to induce immune tolerance in complex autoimmune settings, including Type 1 diabetes in the context of pancreatic islet transplantation. The CELZ-101 platform has ...

Kurtis Cox, 55, calls his recent heart bypass surgery with a new hybrid coronary revascularization (HCR) procedure at Mercy ...

Diamyd Medical receives Notice of Allowance for key retogatein US patent: Stockholm Tuesday, February 10, 2026, 17:00 Hrs [IST] Diamyd Medical, a company develops precision medici ...

Trulieve Cannabis Corp. ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, February 26, 2026 at 8:30 AM Eastern Time ...

Bats have been increasingly identified as hosts for zoonotic pathogens, including but not limited to viruses, bacteria, and protozoa. With few exceptions, ...

Think you’re safe at the top? Think again. Here’s why executives must stop relying on titles for security and start building ...

Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a quivering or irregular heartbeat.

As China's new drug R&D enters the 'deep waters' of homogeneous competition, the path for followers has become increasingly ...

In recent years, a significant shift in U.S. immigration processes has elevated investment-based immigration from a minor strategy to a core tool in the playbook of Indian individuals and families ...

When investors have built a solid portfolio, they can sit back during volatility and consider buying more shares on weakness.